- Home
- MVIS vs BTMD Comparison
MVIS vs BTMD Comparison
Compare MVIS & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MVIS | BTMD |
|---|---|---|
| Founded | 1993 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.6M | 64.4M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MVIS | BTMD |
|---|---|---|
| Price | $0.65 | $1.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $2.25 | $2.25 |
| AVG Volume (30 Days) | ★ 4.6M | 347.5K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 23.91 | ★ 722.22 |
| EPS | N/A | ★ 0.74 |
| Revenue | $664,000.00 | ★ $192,219,000.00 |
| Revenue This Year | $529.06 | $2.03 |
| Revenue Next Year | $168.46 | $6.58 |
| P/E Ratio | ★ N/A | $2.01 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $1.27 |
| 52 Week High | $1.73 | $4.75 |
Technical Indicators
Market Signals| Indicator | MVIS | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.32 | 42.05 |
| Support Level | $0.53 | $1.35 |
| Resistance Level | $0.73 | $1.69 |
| Average True Range (ATR) | 0.05 | 0.16 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 49.67 | 39.67 |
Price Performance
Historical ComparisonAbout MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.